December 20, 2006

Potential New Nasal Spray for Patients Suffering from Chronic Sinusitis

This blog is an OPINION and not medical advice. If there are any questions, please see your physician.

Accentia Pharmaceuticals is in the process of testing a new nasal spray called SinuNase which contains the active ingredient Amphotericin B. Why is this medication of interest to an ENT? Well, it would be one potential treatment for patients with chronic rhinosinusitis in which airborne fungus is the underlying cause of persistent sinusitis in spite of adequate antibiotic and surgical treatment.

This medication is currently undergoing Phase III FDA approval.
Fauquier blog
Fauquier ENT

Dr. Christopher Chang is a private practice otolaryngology, head & neck surgeon specializing in the treatment of problems related to the ear, nose, and throat. Located in Warrenton, VA about 45 minutes west of Washington DC, he also provides inhalant allergy testing/treatment, hearing tests, and dispenses hearing aids.

1 comment:

Anonymous said...

I read that a recent study in the Journal of Allergy and Clinical Immunology showed that this type of treatment has no clinical benefit. Do you still think SinuNase could work?

Banner Map

Pediatric Neck Masses

Adult Neck Mass Workup